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C.J. van Vlijmen-van Keulen,1* J.A. Rauwerda1 and G. Pals21Institute for Cardiovascular Research, and 2Department of Clinical Genetics, VU University Medical Center,
Amsterdam, The NetherlandsObjectives. Elucidation of the genetic background of familial abdominal aortic aneurysm (AAA) suggests a genetic
etiology.
Methods and results. We carried out a genome-wide scan in three Dutch families with four or five affected siblings.
Suggestive loci were further studied by subsequent fine mapping of the locus performed in 101 affected sib-pairs. The
genome-wide scan was performed with 400 DNA markers and results were given as non-parametric, multipoint linkage
scores (NPL). We observed a suggestive linkage for AAA (NPL score 3.25 at D19S902, 72.72 cM) on chromosome 19q in the
three families. After fine mapping on chromosome 19, the NPL score became nominal in the 101 affected sib-pairs. A separate
analysis of the three families with fine mapping revealed a peak with significant evidence for linkage (NPL score 3.95 at
D19S904, 78.08 cM) on chromosome 19q. This peak was situated to the right compared to the region found in a previously
published article for familial AAA on chromosome 19q.
Conclusions. Our results identified a candidate locus in three Dutch families with AAA at chromosome 19q13.3. Separate
analysis of these three families provides evidence for genetic heterogeneity.Keywords: Genome-wide linkage; Familial abdominal aortic aneurysm.Introduction
Abdominal aortic aneurysm (AAA) is a late onset
disease. AAA rarely occurs before the age of 50, but
becomes increasingly common thereafter, affecting 4–
9% of men above the age of 65.1–4 Rupture, the main
complication of AAA, is associated with a mortality of
65–85%.5–7 Many factors are accepted as important in
AAA development, including age, gender, smoking
and hypertension,1,8,9 AAA is frequently familial, with
up to 18% of brothers of the proband having AAA and
familial factors may influence the age of onset of
AAA.10–14 Recently, 233 multiplex families with AAA
were collected from nine different countries, in which
almost one fifth of the families had four or more
affected family members, suggesting a genetic
component.15
In genetic studies, the unravelling of a disease likeng author. C. J. van Vlijmen-van Keulen, Department
urgery, VU University Medical Center, P.O. Box 7057,
sterdam, The Netherlands.
: cj.vanvlijmen@vumc.nl
0029 + 07 $35.00/0 q 2005 Elsevier Ltd. All rights reserAAA is complicated by the late onset of the disease
because at the time of diagnosis (affected) parents have
often deceased; initially unaffected family members
still may develop an AAA in the future (incomplete
penetrance); no DNA is available from affected
siblings who might or might not have died from
AAA, and finally children of the siblings are yet too
young to have developed an AAA. Consequently,
available DNA samples are usually restricted to a
single generation. Additionally, many families are
small in size. The majority of the affected sib-pairs
consist of families with only two affected siblings.
Large families will be more informative and their
unaffected family members may contribute to infor-
mation on the transmittance of alleles.16
The search for susceptibility genes for AAA has
proven difficult. Several candidate gene studies were
unable to provide consistent evidence for an associ-
ation between putative susceptibility genes and
AAA.17 However, in a recent collaborative study
significant linkage was found on chromosome 19q13,
near marker D19S416 at 58.69 cM, with a LOD score of
4.75 (PZ0.00014).18Eur J Vasc Endovasc Surg 30, 29–35 (2005)
doi:10.1016/j.ejvs.2004.12.029, available online at http://www.sciencedirect.com onved.
C. J. van Vlijmen-van Keulen et al.30Because in this collaborative study, the number of
affected family members was an important covariate
and genetic heterogeneity was evident, we performed
a separate analysis of three large families, that were
part of the above mentioned collaborative study, but
came from a single population (Dutch).MethodsClinical diagnosis and definitions
An AAA was defined as an aortic diameter greater
than 3 cm in the infrarenal portion of the aorta, or a
50% increase in diameter of the suprarenal aorta,
confirmed by CT-scan or ultrasound investigation.19
Large families were defined as at least four or more
first-degree relatives, who were still alive and diag-
nosed with an AAA, as confirmed by a physician. In
these families unaffected brothers and sisters were also
invited to participate, as they are informative in the
hereditary transmittance of alleles.
Affected sib-pairs were defined as one or more
siblings, who were still alive and diagnosed with an
AAA, as confirmed by a physician.
No samples or data were available from other
generations, as the age of onset of AAA is above the
age of fifty, at the time point of diagnosis (affected)
parents have often deceased and the children are often
too young to already have developed an AAA.Family collection
The procedure of family collection and participating
hospitals has been described in detail previously, but
afterwards one additional hospital agreed to partici-
pate in our study.20 We selected three large families
with four or more affected family members for
participation into a medium density genome-wide
linkage study (Fig. 1).
High-density mapping was performed in these
three families. Additionally, another 55 families,
comprising of 79 affected sib-pairs, were recruited,
yielding a total collection of 101 affected sib-pairs from
58 families. These 101 affected sib-pairs belonged to 46
families with two, seven families with three, four
families with four, and one family with five affected
siblings. None of the families showed any clinical
symptoms of Ehlers Danlos type IV or Marfan
syndrome.
The medical records of the index patients and their
relatives were reviewed and the diagnoses verified.
Subsequently, the index patients and their relativesEur J Vasc Endovasc Surg Vol 30, July 2005were invited for recording of their medical and family
history and collection of blood samples for DNA
analysis. The presence of major risk factors for AAA,
i.e. smoking, hypertension (WHO criteria), diabetes
mellitus, hypercholesterolaemia and atherosclerotic
manifestations presenting as peripheral, coronary
and cerebral arterial occlusive disease, was not
significantly different in comparison with AAA
patients without a familial predisposition (unpub-
lished data, for definitions see).21
This study was approved by the local ethics
committee and all patients and their family members
gave informed consent.Genotyping
We extracted DNA from peripheral blood samples,
using DNAzol reagent (Invitrogen, Molecular
Research Center, Inc., Cincinnati, OH). For the
genome-wide linkage analysis, the ABI Prism Linkage
Mapping Set v 2.5-MD10 (Applied Biosystems, Tor-
rence, CA, USA) was used. This set consists of 400
DNA markers distributed throughout the genome,
with an average distance of 10 cM. These 400 markers
were multiplexed in 96 polymerase chain reactions
(PCRs). PCR was set up with a Tecan Miniprep 75
pipetting robot (Tecan, Maennedorf, Switzerland) in
384 well plates, that were cycled on a Geneamp 9700
Viper (Applied Biosystems, Torrence CA, USA). The
PCR products were pooled using a separate Tecan
Miniprep 75 pipetting robot and were supplemented
with an LIZ500 internal size standard. Fragment
analysis was performed on an ABI 3100 sequencer
(Applied Biosystems, Torrence, CA, USA).
For the 101 sib-pairs, additional markers, derived
from the ABI Prism Linkage Mapping Set v 2.5-HD5,
with an average distance of 5 cM (panel 78 and 79),
were used for fine mapping of chromosome 19. For the
three large families, also markers were used with a
distance of 1 or 2 cM22 in the area of the suggestive
linkage observed in the genome-wide scan. The
fragment analysis data were analysed with the
Genemapper v 2.5 software (Applied Biosystems,
Torrence, CA, USA).Data management and statistical analysis
For data conversion and analysis, the Allegro version
1.1 computer program for multipoint genetic linkage
analysis was used.23 Results were presented as non-
parametric multipoint LOD scores (NPLs), since, we
dealt with family members of one generation and no
convincing evidence was present from other
Fig. 1. The Figure shows the family trees of three families with abdominal aortic aneurysms (AAA). Filled squares and circles
indicate those in whom AAA was diagnosed. I–IIZdifferent generations and year of birth and death. Pat II:2 in family I did
not participate in the study.
Familial Abdominal Aneurysms 31generations. Marker orders and genetic distances
were obtained from the documentation of Applied
Biosystems. Allele frequencies and sizes of the
markers were obtained from the website of CEPH
(www.cephb.fr) to construct the input files for the
linkage programs. Criteria for significance were
based on guidelines published by Lander and
Kruglyak:24 a LOD scoreO3.6 (P-value!0.00002)
indicates genome-wide significance, a LOD score
between 2.2 and 3.6 (P!0.0007) indicates genome-
wide suggestive linkage and a LOD score between
0.6 (P!0.05) and 2.2 (P!0.01) is considered
nominal.
The critical maximum NPL-score thresholds for
significance at the 5% level were estimated by
simulation with the Allegro computer program.23
We created 1000 artificial data sets for which we
used the original pedigree structure, phenotypeinformation and allele frequencies noted in the
experimental dataset of the three families. This
simulation was generated under the null hypoth-
esis of no linkage.
By using the sample-size of 101 affected sib-pairs,
we had at least a 90% power to detect ‘significant
linkage’ (NPL score of 3.6)24–27 for a locus with a locus-
specific relative risk of four in the absence of locus
heterogeneity.
Since, the exact mode of inheritance is not
known15 and the data available were not sufficient
to establish an exact age-dependent penetrance,
linkage was also assessed using a dominant mode
of inheritance with a reduced penetrance of 80%
and a recessive mode of inheritance. For both
parametric analyses, the programs MEGA2 (data
conversion) and SIMWALK2 (calculations) were
used (data not shown).28–30Eur J Vasc Endovasc Surg Vol 30, July 2005
Fig. 2. Results of the genome-wide scan in the three families with abdominal aortic aneurysms. Each of the boxes represents a
chromosome. The vertical axis indicates the nonparametric multipoint LOD (NPL) score. The horizontal axis inidcates the
centiMorgan distance of the markers used. A maximum NPL score of 3.25 (at 72.72 cM, D19S902) is calculated on
chromosome 19.
C. J. van Vlijmen-van Keulen et al.32ResultsGenome-wide scan
Results of the genome-wide scan are shown in Fig. 2.
According to the criteria of Lander and Kruglyak,24 20
chromosomal regions showed nominal NPL score
peaks. Three chromosomal regions showed suggestive
evidence for linkage. The highest NPL score observed
for the three families was 3.25 (PZ0.04) at D19S902
(72.72 cM, 19q13), followed by 2.30 (PZ0.02) at
D1S2842 (273.46 cM, 1q42–43) and 2.24 (PZ0.03) at
D8S258 (41.55 cM, 8p21).Eur J Vasc Endovasc Surg Vol 30, July 2005Fine mapping on chromosome 19
The fine mapping of chromosome 19, for which 22
markers were used, was performed in all of the 101
affected sib-pairs, including the affected sib-pairs of
the three large families. The results are shown in Fig. 3.
The highest NPL score peak observed in the 101
affected sib-pairs was 1.57 (PZ0.08) at D19S894
(15.55 cM, 19p13).
In this group, the NPL score was negative or around
zero in the region of suggestive evidence for linkage
observed in the genome-wide scan performed in the
three families.
The three large families, for which 41 markers were
Fig. 3. Results linkage analysis on chromosome 19 with
additional markers in 101 sib-pairs with abdominal aortic
aneurysisms. The vertical axis indicates the nonparametric
multipoint LOD (NPL) score. The horizontal axis indicates
the centiMorgan distance of the markers used. A maximum
NPL score is 1.57 at 15.5 cM (D19S894).
Familial Abdominal Aneurysms 33used, were analysed separately (Fig. 4) and showed
significant evidence for linkage, with a NPL score of
3.95 (PZ0.001) at D19S904 (78.08 cM, 19q13.3).
Fig. 2 shows the genome-wide scan on chromosome
19 showing a plateau between 72.72 (D19S902) and
92.56 cM (D19S418). This plateau contained several
hundreds of genes. After fine mapping, the region
became more specific, ranging between 78.08
(D19S904) and 84.08 cM (D19S571) and containing
around 100 genes.Simulation experiments
The significance of the observed NPL statistics was
estimated by simulation. The threshold for the NPL
score occurring with probability of 5% by chance only,
was 3.20. In the genome-wide scan, the multipoint
NPL score was 3.25 on chromosome 19q13 at D19S902
and after fine mapping the NPL score at D19S904 wasFig. 4. Results of the linkage analysis on chromosome 19 with
additional markers in the three families with 4 or 5 affected
siblings with an abdominal aortic aneurysm. The vertical
axis indicates the nonparametric multipoint LOD (NPL)
score. The horizontal axis indicates the centiMorgan distance
of the markers used. The maximum NPL score is 3.95 at
D19S904 (78.08 cM).3.95. In a genome wide scan as defined by Lander and
Kruglyak,24 these values are above the thresholds of
genome-wide ‘suggestive’ and ‘significant’ linkage.
Despite that the sample size of 101 affected sib-pairs
had a 90% power to declare a difference, the multi-
point NPL score turned out to be non-significant
(NPLZ1.57) at chromosome 19q13.Discussion
We identified a candidate locus for familial AAA on
chromosome 19q in three Dutch families with four or
more affected siblings. In order to investigate whether
the suggestive linkage that was initially found on
chromosome 19 in the three large families, suggested a
common locus in familial AAA, linkage analysis was
also performed in the 101 affected sib-pairs. However,
no evidence of linkage was detected in these 101
affected sib-pairs. The high NPL score in the three
large families, compared to the low values in the sib-
pair analysis, indicates that many of the affected sib-
pairs originate from families in which aneurysms are
of a non-genetic origin or of a different genetic origin.
As isolated pairs of sibs are often coincidental and not
the result of a common genetic defect, the average age
of onset of AAA in these sibs is expected to be higher
than observed in the multiplex families. Beside the
index patients, the majority of the first degree-relatives
are diagnosed by screening and the number of
participants in our study is too small to draw
conclusions on age differences.
Fine mapping in the three large families resulted in
significant linkage with a NPL score of 3.95. Although,
the location at chromosome 19q is in agreement with
the previous published article, closer comparison
showed that the peaks have no overlap. This may be
an indication of heterogeneity as these results suggest
that two different genes may be involved in AAA.
Despite gender differences in age at onset there
were no indications for sex-linked inheritance. Appar-
ently, the much younger age of males is not a result of
X-linked inheritance. Apart from a genetic basis, also a
gene-environment interaction may contribute to the
familial clustering of AAA.31
As AAA is a disorder of later life the formation of an
aneurysm can be due to very gradual change of the
strength of the aortic wall during life. Reduced
strength of the aortic wall can be caused by changes
in the synthesis and break down of the extracellular
matrix. Consequently, candidate genes can be found in
several functional groups; the structural proteins of
the connective tissue, the proteinases, the enzymes
involved in the posttranslational modification andEur J Vasc Endovasc Surg Vol 30, July 2005
C. J. van Vlijmen-van Keulen et al.34transcription factors involved in the regulation of
these genes.
Fine mapping on chromosome 19 of the families
with four or more affected siblings showed that the
candidate locus became smaller. Candidate genes will
be selected with a potential interaction with genes
involved in the formation of the extracellular matrix
and in genes involved in development and growth,
e.g. collagen and elastin.32–38
Internet search (www.ncbi.nlm.gov) for candidate
genes on chromosome 19q13.3 revealed two putative
candidate genes for the pathogenesis of AAA.
Fibroblast growth factor 21 (FGF21), the protein
encoded by this gene, is a member of the FGF family.
FGF family members possess broad mitogenic and cell
survival activities and are involved in a variety of
biological processes including embryonic develop-
ment, cell growth, morphogenesis, tissue repair and
invasion. The function of this growth factor has not yet
been elucidated.39
Hyaluronan synthase 1 (HAS1) is a member of the
newly identified vertebrate gene family associated
with encoding of putative hyaluron synthases.
Increased HAS1 expression leads to increased hyalur-
onan (HA) production. HA is actively produced
during wound healing and tissue repair thereby
providing a framework for the ingrowth of blood
vessels and fibroblasts.40
These candidate genes have influence on cell
growth, the growth direction and tissue repair. There-
fore, a mutation in one of these genes may influence
the stability of the aortic wall, which eventually may
result in dilatation. Sequencing of FGF21 in one of the
three families did not reveal mutations in this gene
(unpublished data).
In this region on chromosome 19 also many
hypothetical genes are located, with unknown func-
tion. Sequencing of all these genes is a major effort; so
additional fine mapping of chromosome 19 in other
families may be necessary to zoom in on this region.
Additionally, micro-array studies may give more
insight in the expression of genes in the aneurysm
wall, especially for genes located on chromosome 19.
In conclusion, the results of our genome-wide
linkage analysis and subsequent fine mapping per-
formed in three large families with familial AAA
identified a locus for familial AAA at chromosome
19q13.3. Comparing the results with the previous
collaborative study18 leads to the conclusion that
genetic heterogeneity between different countries or
even families is very likely. Genetic studies may define
subgroups of patients at risk for familial AAA who
would benefit most from ultrasound screenings
programs.Eur J Vasc Endovasc Surg Vol 30, July 2005Acknowledgements
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